Latest Updates

Introduction to the Patient with Rheumatic Disease

    • ACR/SAA/SRTN 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
    • American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee

Viral Hepatitis A

Brittany L Kmush, PhD, Kenrad E Nelson, MD
    • Several safe and effective vaccines exist to prevent hepatitis A infections.
    • Significant morbidity continues to occur in the United States among international travelers, injection drug users, and persons with underlying liver disease.
    • In developing countries, the epidemiologic transition has increased the prevalence of clinically severe hepatitis A infections.

Viral Hepatitis A

Brittany L Kmush, PhD, Kenrad E Nelson, MD
    • Several safe and effective vaccines exist to prevent hepatitis A infections.
    • Significant morbidity continues to occur in the United States among international travelers, injection drug users, and persons with underlying liver disease.
    • In developing countries, the epidemiologic transition has increased the prevalence of clinically severe hepatitis A infections.

Hepatitis B Virus

Ming V. Lin, MD, April Wall, MD
    • Tenofovir alafenamide (AF) was FDA approved in November 2016 for the treatment of chronic hepatitis B. It has enhanced plasma stability and more efficient delivery to the hepatocytes with a lower dose compared with tenofovir disoproxil fumarate (DF). Tenofovir AF has similar efficacy to tenofovir DF but less nephrotoxicity (smaller increase in serum Cr and median changes in estimated GFR) and bone toxicity (smaller mean percentage decrease from baseline hip and spine bone mineral density).
    • Major advances in basic research in hepatitis B are paving the way for the identification of new therapeutic targets with the goal of complete cure with physical elimination of cccDNA.
    • Postmarketing studies have demonstrated a risk of HBV reactivation during treatment with hepatitis C direct antiviral agents, and it is recommended to monitor patients with HBV-HCV coinfection with serial lab tests and consider concomitant HBV treatment analogue for patients who meet the standard criteria for HBV treatment.

Viral Hepatitis A

Brittany L Kmush, PhD, Kenrad E Nelson, MD
    • Several safe and effective vaccines exist to prevent hepatitis A infections.
    • Significant morbidity continues to occur in the United States among international travelers, injection drug users, and persons with underlying liver disease.
    • In developing countries, the epidemiologic transition has increased the prevalence of clinically severe hepatitis A infections.

Introduction to the Patient with Rheumatic Disease

    • ACR/SAA/SRTN 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
    • American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee

Introduction to the Patient with Rheumatic Disease

    • ACR/SAA/SRTN 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
    • American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee

Urticaria and Angioedema

Justin R Chen, MD, David A. Khan, MD
    • Latest BSACI guideline for the management of chronic urticaria and angioedema
    • Latest ACAAISAEM consensus parameter for the evaluation and management of angioedema in the emergency department
    • Latest EAACI, GAAEN, EDF, and WAO guideline for the definition, classification, diagnosis, and management of urticaria
« Previous | Next »
Updates per yearSpecialty updatesNumber of sections